Director/PDMR Shareholding

DXS International

10/02/2025 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250210:nGNEcdbKZ8&default-theme=true


DXS INTERNATIONAL PLC

(AQSE: DXSP)

Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC

The Board of DXS International plc (the “Company” or “DXSP), the AQSE
Growth Market quoted clinical decision support developer and supplier of
clinical decision support systems, has received notification that on 31
January, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in
the Company at a price of 2.89p per share.

Following this transaction Mr Sutcliffe and his wife’s interest in DXS
Ordinary Shares is 1,303.756 Ordinary Shares representing 2.04% of the issued
share capital of the Company.

 1   Details of the person discharging managerial responsibilities / person closely associated                                                                                                                                        
 a)  Name                                                         Mr. Robert Sutcliffe                                                                                                                                                
 2   Reason for the notification                                                                                                                                                                                                      
 a)  Position/status                                              Chairman                                                                                                                                                            
 b)  Initial notification /Amendment                              Initial                                                                                                                                                             
 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                                                    
 a)  Name                                                         DXS INTERNATIONAL PLC                                                                                                                                               
 b)  LEI                                                          2138001R1KEUWTXEVJ44                                                                                                                                                
 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted                                
 a)  Description of the financial instrument, type of instrument  Ordinary Shares of 0.33p each                                                                                                                                       
                                                                                                                                                                                                                                      
     Identification code                                          ISIN GB00B2Q6HZ92                                                                                                                                                   
                                                                                                                                                                                                                                      
 b)  Nature of the transaction                                    Purchase of shares                                                                                                                                                  
 c)  Price(s) and volume(s)                                                                                                                                                                                                           
                                                                                                           Price(s)                                 Volume(s)                                                                         
                                                                                                           2.89p                                    30,000                                                                            
 d)  Aggregated information                                                                                                                                                                                                           
                                                                                                                                                                                                                                      
     - Aggregated volume                                                                                                                                                                                                              
                                                                                                                                                                                                                                      
     - Price                                                                                                                                                                                                                          
                                                                                                                                                                                                                                      
 e)  Date of the transaction                                      7 February 2025                                                                                                                                                     
 f)  Place of the transaction                                     Aquis Stock Exchange                                                                                                                                                

The Directors of DXS International plc accept responsibility for this
announcement.

Contacts:

 David Immelman DXS International plc www.dxs-systems.com                      01252 719800   
 AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce  020 3764 2341  

Notes to Editors

About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its projected
efficiency savings